Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2020-06-20
2023-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Progesterone Levels and Pregnancy Results
NCT04400149
Fibroids and the Risk of Miscarriage: a Prospective Observational Study in an Early Pregnancy Population
NCT06986616
Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion
NCT04232189
Risk Factors of Ectopic Pregnancy
NCT00194207
New Biomarkers Associated With the Risk of Premature Delivery.
NCT04067908
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Monitoring of pregnancy, including data on:
* maternal age and other demographic characteristics;
* ultrasound measurement of fetal heart rate (FHR) and crown-rump length (CRL)
No interventions assigned to this group
sFlt-1, Doppler and NK cells types group
Monitoring of pregnancy, including data on:
* maternal age and other demographic characteristics;
* ultrasound measurement of fetal heart rate (FHR) and crown-rump length (CRL), uterine arteries PI, and other parameters;
* measurement of serum sFlt-1, PLGF, and glycodelin-A levels, as well as other parameters;
* measurement of CD16+, CD56+, and other subpopulations of NK cells;
Markers of ultrasound
CRL, HR, and other ultrasound measurements.
Immunologic factors
Measurement of NK cells subpopulations types in the maternal serum
Serum factors
Measuring the maternal serum concentration of sFlt-1, PLGF, glycodelin-A, and other substances.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Markers of ultrasound
CRL, HR, and other ultrasound measurements.
Immunologic factors
Measurement of NK cells subpopulations types in the maternal serum
Serum factors
Measuring the maternal serum concentration of sFlt-1, PLGF, glycodelin-A, and other substances.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* normal THS/T4 levels
* no uterine malformations
* BMI \< 27
* signed informed consent
Exclusion Criteria
* elevated THS/T4 levels
* uterine malformations
* BMI \> 27
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Orthogyn Medical Center, Bulgaria
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Petar Ignatov
Assist. Prof. Petar Ignatov, MD, Ph.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Petar N Ignatov, PhD
Role: PRINCIPAL_INVESTIGATOR
Orthogyn Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Orthogyn Medical and Dental Center
Sofia, , Bulgaria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MIS-CARE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.